Discrepancies in drug approvals: A global dilemma

Cancer. 2015 Sep 15;121(18):3360-1. doi: 10.1002/cncr.29484. Epub 2015 Jun 16.

Authors

Michelle K Wilson¹, Katherine Karakasis¹, Amit M Oza¹

Affiliation

¹ Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

PMID: 26079099
DOI: 10.1002/cncr.29484

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Agents*
Drug Approval*
Humans

Substances

Antineoplastic Agents